Afternoon Report / NAB rallies on decent trading update (CBA, MIN, AGL, AMP, CMA, MGR, RIO, NAB)

By Market Matters 08 February 18

NAB rallies on decent trading update (CBA, MIN, AGL, AMP, CMA, MGR, RIO, NAB)

Market Matters Afternoon Report 8th February 2018


Another calmer day for Aussie stocks with the market having bouts of indecision in early trade before buyers settled in and pushed the index up throughout the afternoon – a decent close near the session highs with the Telco stocks doing most of the heavy lifting. On the flipside, we saw weakness in the Energy space which is understandable given the decent move out of Crude in recent times.

The ASX 200 put on +13pts or +0.24% to close at 5890 – US Futures are ticking around par

ASX 200 Intra-Day Chart


ASX 200 Daily Chart


Rio Tinto (RIO) – reported yesterday and the numbers were good, underlying earnings the best since 2014 and these guys are very flush with cash – the balance sheet is in exceptional condition and there’s a strong chance of more cash going back to shareholders throughout 2018. The stock was down today on the overnight metals selloff  courtesy of a stronger $US however the inflationary trade that should continue to play out in 2018 is supportive of RIO. We saw it on Tuesday when the mkt was weak, most buying into the weakness was seen amongst the miners. RIO lost -0.98% to close at $77.54 today

Rio Tinto Daily Chart

AGL (AGL)  First half result was weak – they missed in terms of both revenue and underlying earnings + the divi was a miss as well and the stock was sold off by -2.05% to close at $22.01, its lowest level since early 2017

AMP (AMP)  The mkt dislikes AMP – I’m not a fan either – and the result today was simply a case of being better than feared and the stock put +3.58%. Earnings a slight beat, divi was inline but underlying trends here remain weak, margins in wealth are weakening and just really, not much to entice me to step up and buy AMP.  

Centuria (CMA)  1H18 operating NPAT of $19.9m which was inline / +ve while FY18 guidance reaffirmed  EPS  18.6cps, DPS 18.1cps – all inline. Earnings here have experienced  ~93% growth relative to pcp courtesy of acquisitions over the past 12 months - stock up +1.29% as a result . they will continue to be acquirers…

Mirvac (MGR)  better headline numbers than the market thought however that was largely driven by the interest expense that came in lower than expected, as did tax – so quality of the beat low. FY18 Guidance maintained at 6-8% EPS growth, or EPS of 15.3-15.6cps, with a FY18DPS  of 11.0c + they also announced plans to buy back 2.6% of its shares via an  on market buy-back.  It will commence 23 Feb 2018.

Mineral Resources (MIN)  good result here for MIN and the stock rallied hard on the back of it – they always report at a weird time, go into a halt intra day and the mkt panics then realises it’s simply earnings – which were good. Earnings +16% higher and dividend bigger than thought. Stock rallied +4.21% to close at $19.04 following a recent pretty savage sell off.

NAB   After trading near a 1 year low yesterday NAB trading update was good today – cash earnings +3% on last year, capital ok, bad debts well behaved, strong articulation of strategy and the stock bounced hard +2.34% to close at $28.90 – with some obvious rotation from the other banks – CBA down  -0.36% the biggest funding vehicle, while the others were up, but not as much as NAB.

NAB Daily Chart


1.Broker Moves;Obviously reporting season is important to get a feel for underlying earnings / trends etc, however it’s also worth looking at broker reactions to results, it provides a good read into market positioning / views on particular stocks.

Here’s yesterday’s moves;

  • Downgraded to Neutral at Macquarie; PT A$14
  • Upgraded to Neutral at UBS; Price Target A$14
  • GTN Rated New Buy at Canaccord; PT A$3.65
  • Steadfast Upgraded to Buy at Morningstar
  • Transurban Downgraded to Neutral at Goldman; PT A$12.26
  • Macquarie Atlas Downgraded to Sell at Goldman; PT A$5.31
  • Greencross Downgraded to Neutral at UBS; PT A$6.15
  • Genworth Australia Raised to Neutral at Evans and Partners
  • Sonic Healthcare Upgraded to Neutral at Credit Suisse; PT A$24
  • CBA Upgraded to Buy at Bell Potter; Price Target A$83.90

We had a few questions around the topic of consensus recently given we write about it regularly, so here’s our take using CBA as an example. 14 local brokers cover CBA (Shaw and Partners do but we’re in the middle of an analyst change), of them, 57% have holds, 21% buys and the same sells. The 12 month price target is the average of all PT’s and the return potential is the different between current price and PT. All pretty straight forward – and no really earth shattering stuff.


Looking at earnings, the numbers below are the average of analysts’ expectations courtesy of Bloomberg. As you can see, earnings per share are expected to be $2.875 between 31 Dec 17 and 30th June 18. If CBA deliver that, they’ll have FY EPS of $5.69. – which all things being equal the market is positioned for.  The real key to using consensus is to see how the market is positioned  around a stock – are they optimistic or pessimistic? We prefer it when analysts are pessimistic more so than when analysts are optimistic as a group. Imbedded optimism creates more chance for disappointment. When our expectations around a particular stocks diverge from the consensus view, that’s when the best opportunities can arise.


Here’s a quick look at TS Lim at Bells – no 1 rated analyst of CBA according to Bloomberg at the moment – and his prevailing calls. Yesterday, he upgraded to a BUY and $83.90 target. 



No changes to the portfolio’s today


Have a great night

James & the Market Matters Team


Market Matters may hold stocks mentioned in this report. Subscribers can view a full list of holdings on the website by clicking here. Positions are updated each Friday, or after the session when positions are traded.


All figures contained from sources believed to be accurate.  Market Matters does not make any representation of warranty as to the accuracy of the figures and disclaims any liability resulting from any inaccuracy.  Prices as at 08/02/2018. 4.40PM  

Reports and other documents published on this website and email (‘Reports’) are authored by Market Matters and the reports represent the views of Market Matters. The MarketMatters Report is based on technical analysis of companies, commodities and the market in general. Technical analysis focuses on interpreting charts and other data to determine what the market sentiment about a particular financial product is, or will be. Unlike fundamental analysis, it does not involve a detailed review of the company’s financial position.

The Reports contain general, as opposed to personal, advice. That means they are prepared for multiple distributions without consideration of your investment objectives, financial situation and needs (‘Personal Circumstances’). Accordingly, any advice given is not a recommendation that a particular course of action is suitable for you and the advice is therefore not to be acted on as investment advice. You must assess whether or not any advice is appropriate for your Personal Circumstances before making any investment decisions. You can either make this assessment yourself, or if you require a personal recommendation, you can seek the assistance of a financial advisor.  Market Matters or its author(s) accepts no responsibility for any losses or damages resulting from decisions made from or because of information within this publication. Investing and trading in financial products are always risky, so you should do your own research before buying or selling a financial product.

The Reports are published by Market Matters in good faith based on the facts known to it at the time of their preparation and do not purport to contain all relevant information with respect to the financial products to which they relate. Although the Reports are based on information obtained from sources believed to be reliable, Market Matters does not make any representation or warranty that they are accurate, complete or up to date and Market Matters accepts no obligation to correct or update the information or opinions in the Reports.

If you rely on a Report, you do so at your own risk. Any projections are estimates only and may not be realised in the future. Except to the extent that liability under any law cannot be excluded, Market Matters disclaims liability for all loss or damage arising as a result of any opinion, advice, recommendation, representation or information expressly or impliedly published in or in relation to this report notwithstanding any error or omission including negligence.

To unsubscribe. Click Here